FI104175B1 - Menetelmä terapeuttisesti käyttökelpoisten imidatso[2,1-b][3]bentsatsepiinijohdannaisten valmistamiseksi ja välituotteita - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten imidatso[2,1-b][3]bentsatsepiinijohdannaisten valmistamiseksi ja välituotteita

Info

Publication number
FI104175B1
FI104175B1 FI935556A FI935556A FI104175B1 FI 104175 B1 FI104175 B1 FI 104175B1 FI 935556 A FI935556 A FI 935556A FI 935556 A FI935556 A FI 935556A FI 104175 B1 FI104175 B1 FI 104175B1
Authority
FI
Finland
Prior art keywords
4alkyl
represents hydrogen
4alkyloxy
halo
substituted
Prior art date
Application number
FI935556A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI104175B (fi
FI935556A0 (fi
FI935556A (fi
Inventor
Frans Eduard Janssens
Gaston Stanislas Marcell Diels
Joseph Elisabeth Leenaerts
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI935556A0 publication Critical patent/FI935556A0/fi
Publication of FI935556A publication Critical patent/FI935556A/fi
Application granted granted Critical
Publication of FI104175B publication Critical patent/FI104175B/fi
Publication of FI104175B1 publication Critical patent/FI104175B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Paper (AREA)
FI935556A 1991-06-13 1993-12-10 Menetelmä terapeuttisesti käyttökelpoisten imidatso[2,1-b][3]bentsatsepiinijohdannaisten valmistamiseksi ja välituotteita FI104175B1 (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US71448691A 1991-06-13 1991-06-13
US71448691 1991-06-13
US85363192A 1992-03-18 1992-03-18
US85363192 1992-03-18
EP9201330 1992-06-09
PCT/EP1992/001330 WO1992022551A1 (en) 1991-06-13 1992-06-09 IMIDAZO[2,1-b][3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE

Publications (4)

Publication Number Publication Date
FI935556A0 FI935556A0 (fi) 1993-12-10
FI935556A FI935556A (fi) 1993-12-10
FI104175B FI104175B (fi) 1999-11-30
FI104175B1 true FI104175B1 (fi) 1999-11-30

Family

ID=27109168

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935556A FI104175B1 (fi) 1991-06-13 1993-12-10 Menetelmä terapeuttisesti käyttökelpoisten imidatso[2,1-b][3]bentsatsepiinijohdannaisten valmistamiseksi ja välituotteita

Country Status (28)

Country Link
US (1) US5468743A (zh)
EP (2) EP0588858B1 (zh)
JP (1) JP2845407B2 (zh)
KR (1) KR0184017B1 (zh)
CN (2) CN1033586C (zh)
AT (1) ATE250061T1 (zh)
AU (1) AU652840B2 (zh)
CA (1) CA2103242C (zh)
DE (1) DE69233205T2 (zh)
DK (1) DK0588858T3 (zh)
DZ (1) DZ1582A1 (zh)
ES (1) ES2207632T3 (zh)
FI (1) FI104175B1 (zh)
HR (1) HRP920155A2 (zh)
HU (2) HU221016B1 (zh)
IE (1) IE921918A1 (zh)
IL (1) IL101850A (zh)
MA (1) MA22553A1 (zh)
MX (1) MX9202856A (zh)
NO (2) NO300636B1 (zh)
NZ (1) NZ242774A (zh)
PT (1) PT588858E (zh)
SG (1) SG47823A1 (zh)
SI (1) SI9200105B (zh)
TN (1) TNSN92048A1 (zh)
TW (1) TW218381B (zh)
WO (1) WO1992022551A1 (zh)
YU (1) YU61192A (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition
GR1001393B (el) * 1992-10-12 1993-10-29 Janssen Pharmaceutica Nv Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.
US5932569A (en) * 1992-12-04 1999-08-03 Janssen Pharmaceutica, N.V. Triazolobenzazepine derivatives
CN1042228C (zh) * 1993-07-13 1999-02-24 詹森药业有限公司 抗过敏咪唑并吖庚因
TW382017B (en) * 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
TW527186B (en) 1996-03-19 2003-04-11 Janssen Pharmaceutica Nv Fused imidazole derivatives as multidrug resistance modulators
AU1146099A (en) * 1997-09-18 1999-04-05 Janssen Pharmaceutica N.V. Fused imidazole derivatives for improving oral bioavailability of pharmaceuticalagents
SI1144411T1 (en) * 1998-12-19 2005-10-31 Janssen Pharmaceutica N.V. Antihistaminic spiro compounds
EP1401838B1 (en) 2001-06-12 2014-03-26 Janssen Pharmaceutica NV Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
CN1160557C (zh) 2001-09-03 2004-08-04 北京埃索特核电子机械有限公司 钴60γ射线源-碘化铯或钨酸镉阵列探测器集装箱检测设备
ATE478075T1 (de) 2005-03-08 2010-09-15 Janssen Pharmaceutica Nv Diazaspiro-ä4,4ü-nonanderivate als neurokinin- (nk1)-antagonisten
US20070077303A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
JP5292277B2 (ja) * 2006-03-31 2013-09-18 ビスタコン・フアーマシユーチカルズ・エルエルシー 眼アレルギーの処置
US20080139531A1 (en) * 2006-12-04 2008-06-12 Alcon Manufacturing Ltd. Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
AR066016A1 (es) * 2007-04-11 2009-07-15 Alcon Res Ltd Uso de un inhibidor del tnf alfa junto con una antihistamina para tratar la rinitis alergica y la conjuntivitis alergica
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
RU2012117141A (ru) * 2009-10-01 2013-11-10 Алькон Рисерч, Лтд. Композиции олопатадина и способы их применения
AR079170A1 (es) * 2009-12-10 2011-12-28 Lilly Co Eli Compuesto de ciclopropil-benzamida-imidazo-benzazepina inhibidor de diacil-glicerol aciltransferasa, sal del mismo, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para el tratamiento de obesidad o para mejorar la sensibilidad a insulina y compuesto intermedio par
KR20140074881A (ko) * 2011-06-29 2014-06-18 알러간, 인코포레이티드 두드러기의 치료에서 이용을 위한 알카프타딘
WO2014080259A1 (en) * 2012-11-21 2014-05-30 Enaltec Labs Pvt. Ltd. Novel polymorphic forms of alcaftadine
WO2014083571A1 (en) * 2012-11-29 2014-06-05 Neuland Laboratories Limited A process for the preparation of alcaftadine
WO2014087208A2 (en) * 2012-12-06 2014-06-12 Enaltec Labs Pvt. Ltd. A process of preparing alcaftadine
US9682984B2 (en) 2013-03-25 2017-06-20 Crystal Pharma S.A.U. Methods for the preparation of alcaftadine
CN103408549B (zh) * 2013-06-14 2016-01-20 苏州汇和药业有限公司 一种阿卡他定中间体的制备方法
AU2015308350B2 (en) 2014-08-29 2020-03-05 Tes Pharma S.R.L. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
CN104710427A (zh) * 2014-12-20 2015-06-17 威海法莫斯特医药技术开发有限公司 一种阿卡他定新晶型
CN104860920B (zh) * 2015-04-15 2017-08-25 武汉武药科技有限公司 一种阿卡他定中间体的制备方法
CN105130993B (zh) * 2015-07-28 2018-01-12 武汉武药科技有限公司 一种合成阿卡他定的新氧化方法
CN104987337B (zh) * 2015-07-28 2018-01-12 武汉武药科技有限公司 一种制备阿卡他定的氧化方法
EP3496662A4 (en) 2016-08-12 2019-10-30 Silk Technologies Ltd. PROTEIN DERIVED FROM SILK FOR THE TREATMENT OF INFLAMMATION
CN108727384A (zh) * 2018-07-07 2018-11-02 张正光 一种阿卡他定中间体的制备方法
BR112022024840A2 (pt) 2020-06-15 2022-12-27 Alkem Laboratories Ltd Combinação de alcaftadina e um corticosteroide
CN117120029A (zh) 2021-04-01 2023-11-24 阿尔克姆实验室有限公司 包含阿卡他定的鼻用组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148903A (en) * 1977-07-28 1979-04-10 Merck & Co., Inc. Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines
GB8900380D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives
EP0552292B1 (en) * 1990-10-10 1995-06-21 Schering Corporation Substituted imidazobenzazepines and imidazopyridoazepines
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv History 01 -) 4 - Pipridinyl - and Pipridinylidene (- Imidazo] A-1,2 [Pirolo, Thiano or Purano (] 3,2 [Azpin, their preparation and pharmaceutical preparations containing them and composition

Also Published As

Publication number Publication date
IL101850A0 (en) 1992-12-30
DZ1582A1 (fr) 2002-02-17
SG47823A1 (en) 1998-04-17
IE921918A1 (en) 1992-12-16
FI104175B (fi) 1999-11-30
WO1992022551A1 (en) 1992-12-23
JPH06507889A (ja) 1994-09-08
YU61192A (sh) 1994-09-09
NO300636B1 (no) 1997-06-30
ATE250061T1 (de) 2003-10-15
ES2207632T3 (es) 2004-06-01
IL101850A (en) 1996-01-31
DE69233205D1 (de) 2003-10-23
PT588858E (pt) 2004-02-27
CA2103242A1 (en) 1992-12-14
AU652840B2 (en) 1994-09-08
HU211289A9 (en) 1995-11-28
AU1900192A (en) 1993-01-12
SI9200105B (en) 2001-10-31
CN1033586C (zh) 1996-12-18
EP0588858B1 (en) 2003-09-17
FI935556A0 (fi) 1993-12-10
CN1070368C (zh) 2001-09-05
CN1142360A (zh) 1997-02-12
HU221016B1 (hu) 2002-07-29
FI935556A (fi) 1993-12-10
US5468743A (en) 1995-11-21
HU9303553D0 (en) 1994-04-28
MA22553A1 (fr) 1992-12-31
DE69233205T2 (de) 2004-06-24
NO934492L (no) 1994-01-04
SI9200105A (en) 1992-12-31
CA2103242C (en) 2002-11-12
HUT70529A (en) 1995-10-30
KR0184017B1 (ko) 1999-05-01
JP2845407B2 (ja) 1999-01-13
MX9202856A (es) 1992-12-01
NO934492D0 (no) 1993-12-09
NZ242774A (en) 1995-02-24
HRP920155A2 (en) 1994-08-31
EP0588858A1 (en) 1994-03-30
TNSN92048A1 (fr) 1993-06-08
EP0518435A1 (en) 1992-12-16
DK0588858T3 (da) 2004-01-26
TW218381B (zh) 1994-01-01
CN1068118A (zh) 1993-01-20

Similar Documents

Publication Publication Date Title
FI104175B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten imidatso[2,1-b][3]bentsatsepiinijohdannaisten valmistamiseksi ja välituotteita
FI104077B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten imidatso[1,2-a](pyrrolo-, tieno- tai furano)[3,2-d]atsepiinijohdannaisten valmistamiseksi ja välituote
HK1052687A1 (en) Preparation of a camptothecin derivative by intramolecular cyclisation.
AU2174288A (en) Lactam derivatives
GR3031500T3 (en) NOVEL 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES
NO950202L (no) Tetracykliske forbindelser, fremgangsmåter og intermediater for fremstilling og anvendelse derav
DE69129165D1 (de) Prozess zur Darstellung von Lactamderivaten
DE69332929D1 (de) ANTIALLERGISCHE IMIDAZO[1,2-a]THIENO[2,3-d]AZEPINDERIVATE

Legal Events

Date Code Title Description
MA Patent expired